Russell Frank Company’s Acadia Pharmaceuticals ACAD Stock Holding History

Russell Frank Company’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$150K	Sell	5,372 -10,165	-65%	-$222K	﹤0.01%	2732
2015 Q4	$557K	Buy	+15,537	New	+$547K	﹤0.01%	2461
2014 Q2	–	Sell	-41,986	Closed	-$854K	–	2765
2014 Q1	$854K	Sell	41,986 -61,173	-59%	-$1.55M	﹤0.01%	2155
2013 Q4	$2.44M	Sell	103,159 -59,708	-37%	-$1.41M	﹤0.01%	1612
2013 Q3	$4.47M	Sell	162,867 -26,021	-14%	-$544K	0.01%	1397
2013 Q2	$3.43M	Buy	+188,888	New	+$2.6M	0.01%	1471

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Russell Frank Company's ACAD Position: Q1 2016 in Review

Russell Frank Company reduced its Acadia Pharmaceuticals (ACAD) stake by 65% in Q1 2016, selling an estimated $222K and leaving 5,372 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

Russell Frank Company first reported a position in ACAD in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.47M in Q3 2013. 212 funds tracked by Wall St. Rank hold ACAD as of Q1 2016.

Russell Frank Company held 5,372 shares of Acadia Pharmaceuticals worth $150K as of Q1 2016.
Russell Frank Company sold 10,165 Acadia Pharmaceuticals shares in Q1 2016, an estimated $222K.
Acadia Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2732 holding.
Russell Frank Company first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
Russell Frank Company's Acadia Pharmaceuticals position peaked at $4.47M in Q3 2013.
212 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.